Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Multiple predicted targets" does not refer to a single biological molecule, receptor, or enzyme. Instead, it is a descriptive label used in computational biology, network pharmacology, and drug discovery to indicate that a specific compound or microRNA is hypothesized to interact with a variety of different proteins (nih.gov, plos.org). This designation often arises from in silico screening or target prediction algorithms when a definitive primary target has not yet been experimentally validated or when a drug is intentionally designed for polypharmacology (darpa.mil). In a therapeutic context, having multiple predicted targets suggests a broad-spectrum profile, which can be advantageous for treating complex diseases but also poses significant challenges regarding off-target effects and regulatory approval. Because it is a collective term for an uncharacterized or diverse set of proteins, it lacks specific molecular classifications or defined biological functions (researchgate.net).
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple predicted targets.